A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State

OBJECTIVE: To examine the efficacy of ziprasidone vs. placebo for the depressive mixed state in patients with bipolar disorder type II or major depressive disorder (MDD). METHODS: 73 patients were randomized in a double-blinded, placebo-controlled study to ziprasidone (40-160 mg/d) or placebo for 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Patkar, Ashwin, Gilmer, William, Pae, Chi-un, Vöhringer, Paul A., Ziffra, Michael, Pirok, Edward, Mulligan, Molly, Filkowski, Megan M., Whitham, Elizabeth A., Holtzman, Niki S., Thommi, Sairah B., Logvinenko, Tanya, Loebel, Antony, Masand, Prakash, Ghaemi, S. Nassir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335844/
https://www.ncbi.nlm.nih.gov/pubmed/22545088
http://dx.doi.org/10.1371/journal.pone.0034757

Ejemplares similares

Ejemplares similares